Mounjaro, NHS

A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a ...
Actor and comedian Jim Gaffigan made sure his 50-pound weight loss was funny business, discussing the topic in his November ...
But their weight-loss properties grabbed the attention of the public and ... firms struggling to manage ballooning costs ...
A drug dubbed the “King Kong of weight loss jabs” will start being given to the most dangerously obese in the New Year. However the NHS spending watchdog has announced Mounjaro will only be ...
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
Eli Lilly (NYSE:LLY) plans to boost production of its popular diabetes and weight-loss medications with a $3B expansion of ...